Neil Abdollahian
Company: Santa Ana Bio
Job title: Chief Business Officer
Seminars:
Evaluating Bi-Specific Antibody & Cell Engager Targets, Safety & Efficacy to Uncover Their Commercial Potential 12:10 pm
Exploring emerging classes of cell engager and bispecific therapies, evaluating target populations, including macrophages, to identify applications in wider autoimmune diseases Comparing toxicity concerns for a broad population or efficacy in more targeted populations to evaluate the safety of engager and antibody applications Evaluating the safety and efficacy of bispecific antibody & cell engagers, in…Read more
day: Day Two